Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pediatrics, Perinatology and Child Health
Reference122 articles.
1. Jemec GBE. Hidradenitis suppurativa. N Engl J Med. 2012;366:158–64. https://doi.org/10.1056/NEJMcp1014163.
2. Ingram J. Hidradenitis suppurativa: Pathogenesis, clinical features, and diagnosis - UpToDate. UpToDate 2022. https://www-uptodate-com.myaccess.library.utoronto.ca/contents/hidradenitis-suppurativa-pathogenesis-clinical-features-and-diagnosis?search=hidradenitis&source=search_result&selectedTitle=2~82&usage_type=default&display_rank=2. Accessed 10 March 2023.
3. Zouboulis Cc, Desai N, Emtestam L, Hunger Re, Ioannides D, Juhász I, et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol. 2015;29:619–44. https://doi.org/10.1111/jdv.12966.
4. Alikhan A, Sayed C, Alavi A, Alhusayen R, Brassard A, Burkhart C, et al. North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: topical, intralesional, and systemic medical management. J Am Acad Dermatol. 2019;81:91–101. https://doi.org/10.1016/j.jaad.2019.02.068.
5. Mikkelsen PR, Jemec GBE. Hidradenitis suppurativa in children and sdolescents: a review of treatment options. Pediatr Drugs. 2014;16:483–9. https://doi.org/10.1007/s40272-014-0091-3.